Hypothalamic monoamines and neuropeptides in dementia

Eur Neuropsychopharmacol. 1991 May;1(2):165-8. doi: 10.1016/0924-977x(91)90718-a.

Abstract

The concentrations of monoamines and various neuropeptides were determined in the hypothalamus of brains from patients with Alzheimer's disease and vascular dementia (n = 26) and compared with control values (n = 21). Decreased concentrations of 5-hydroxyindoleacetic acid (P less than 0.05) and homovanillic acid (P less than 0.01) were found, and increased arginine vasopressin- (P less than 0.01), galanin- (P less than 0.05) and somatostatin- (P less than 0.01) like immunoreactivity. It is proposed that this disequilibrium may be important for certain circadian symptoms, e.g. the changes in sleep/wake rhythms that are rather often observed in dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / metabolism
  • Biogenic Monoamines / metabolism*
  • Dementia / metabolism*
  • Dementia, Vascular / metabolism
  • Female
  • Humans
  • Hypothalamus / metabolism*
  • Male
  • Neuropeptides / metabolism*

Substances

  • Biogenic Monoamines
  • Neuropeptides